Interventional Cardiology Devices Market to grow at an Impressive CAGR During the Forecast Period
Rising prevalence of cardiovascular
diseases is driving the growth in Global Interventional Cardiology Devices
Market in the forecast period, 2022-2026.
According
to TechSci Research report, “Global Interventional
Cardiology Devices Market By Product Type
(Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters,
Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others) By
End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others) By
Region, Competition Forecast & Opportunities, 2026”,
the global interventional cardiology devices market is projected to grow at an
impressive CAGR in the forecast period, 2022-2026. The market growth can be attributed to the rising
prevalence of the non-communicable diseases which is increasing because of the
unhealthy lifestyle habits are major factors that are driving the global
interventional cardiology devices market growth in the upcoming five years.
Lifestyle changes like consumption of excess salt, saturated fats, sugars along
with the lack of physical workouts and alcohol and tobacco abuses has put a lot
of stress on the heart functions of the population and there by increasing the
instance of the heart related target diseases. To diagnose such diseases and
provide the treatment, the medical devices are utilized and thus it is boosting
the growth of the global interventional cardiology devices market in the next
five years.
Interventional
cardiology devices are the minimally invasive devices that are specifically
instilled in the diagnostic and the surgical procedures related to the heart.
These include angioplasty balloons, that is a specially designed catheter that
carries a balloon in the artery which is inflated to release the blockage and
make way for the artery to carry the blood. In the procedure a stent is often
installed and left in the artery to keep the blockage open for further flow of
the blood. This stent device is also known as the angioplasty stent, which is
another type of interventional cardiology device. Artery blockage is very
common among the obese, diabetic, patients. If the patient is a regular smoker
condones an irregular diet the risks of cardiovascular disease increase many
folds thus, the factor can be termed as a major driver of the market growth in
the future five years.
Furthermore,
technological advancements in the guidewires and stents on grounds of excellent
tip shape retention, improved flexibility with minimal deformity, and
cost-effective product is expected to boost the market growth in the forecast
period, 2022-2026.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on " Global Interventional
Cardiology Devices Market"
https://www.techsciresearch.com/report/interventional-cardiology-devices-market/7381.html
The global interventional
cardiovascular devices market is segmented by product type, end user, regional
distribution, and competitive landscape. Based on end user the market is
further fragmented into hospitals & clinics, ambulatory surgery centers, and
others. Hospitals & clinics are anticipated to assert its dominance over
the market owing to the availability of the pre- and post-surgery services
along with the surgery in a same place along with the affordability of the
devices by the hospitals is driving the growth of the segment in the market. As
compared to the smaller clinics hospitals and specialized clinics can afford
the in-expensive devices and avail the refunding from the government which is a
major growth driver of the market.
Some of the major
competitors in the market are Medtronic Plc., Boston Scientific Corporation,
Abbott Laboratories, Inc., Biotronik, Inc., Edward LifeSciences Corporation,
Cardinal Health, Inc., iVascular - Dispositivos Cardiovasculares, B. Braun
Melsungen AG, Terumo Corporation, Biosensors International Group Ltd, Cordis
Corporation, Cook Medical Inc., C. R. Bard, Inc, MicroPort Scientific
Corporation, Stentys SA, among others. Other strategies include partnerships
and technological advancements. In the year 2020, one of the top players Boston
Scientific Corporation gained FDA approval for its latest product Ranger
Paclitaxel-Coated PTA Balloon Catheter, indicated for percutaneous transluminal
angioplasty (PTA) procedures.
Download Sample
Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7381
Customers can also request for 10% free
customization on this report.
“North American region is an expected
promising sector for the future market growth. The market is bound to grow on
the attributes like presence of sophisticated healthcare infrastructure,
favorable government initiatives pertaining to product development, and high
patient awareness levels coupled with relatively higher healthcare expenditures
in the region. Along with North America, Europe is also expected to hold
significant market share in the forecast period owing its growth to the rising
incidences of obesity and changing lifestyle. Dietary irregularities and
growing number of smokers is responsible for the expected future growth. Asia
Pacific region has the huge population that is over the age of 60 years, that
is driving the market growth in the upcoming five years,” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global management
consulting firm.
“Global Interventional
Cardiology Devices Market By Product Type (Angioplasty Balloons, Angioplasty
Stents, Structural Heart Devices, Catheters, Plaque Modification Devices,
Hemodynamic Flow Alteration Devices, Others) By End User (Hospitals &
Clinics, Ambulatory Surgery Centers, Others) By Region, Competition Forecast
& Opportunities, 2026”, has evaluated the future
growth potential of global interventional cardiology devices and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global interventional cardiology devices.
Contact
Mr. Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]
Web: https://www.techsciresearch.com/